CYP3A4 and infection: It is, therefore, important to investigate the impact of pharmacogenetic variations, including CYP3A haplotypes, on artemether–lumefantrine in a larger cohort in addition to other parameters such as pregnancy, concomitant drug use and comorbidities/infections in the Ghanaian population.